Temedica partners with NOVENTI to enhance Permea generated insights to improve patient care

PRESS RELEASE

Temedica partners with NOVENTI to enhance Permea generated
insights to improve patient care

• Partnership between Temedica, a leading digital health and health insights
company, and NOVENTI Health SE, the largest provider of enterprise
resource planning (ERP) systems and claims management solutions for
pharmacies in Germany
• Jointly generating new healthcare insights through Temedica's new data
analytics platform Permea
• NOVENTI will contribute specific health information to further enrich
Temedica’s Permea analyses and insights

Munich, Germany, February 01, 2022 – Temedica GmbH, a leading digital health
and health insights company, today announced its collaboration with NOVENTI
Health SE, the largest provider of enterprise resource planning (ERP) systems and
claims management solutions for pharmacies in Germany. Temedica and NOVENTI
will combine their expertise and capabilities to develop new healthcare insights
through Temedica’s data analytics platform, Permea. NOVENTI will add specific
health information to further enrich Permea´s insights into patient care. Permea is
the data analytics platform recently launched by Temedica to gain a new
understanding of healthcare for medical research, development and application of
therapies, based on Temedica’s proprietary patient-generated, real-world data.

Dr. Benjamin Friedrich, Chief Medical Officer of Temedica, said:
“We are delighted to welcome NOVENTI, a renowned player in the German and
European healthcare market as a partner for Permea. Joining forces will enable
us to advance our insights to a new level. Temedica’s mission is to place the
patient in the center of healthcare and overcome limitations and shortages of
insight and knowledge in existing healthcare systems. The partnership with
NOVENTI supports our goal of delivering an accurate view of the patient’s
real-life needs and preferences."

Dr. Sven Jansen, Member of NOVENTI’s Executive Board said:
"Healthcare digitalization offers unprecedented opportunities to individualize
patient treatments. With Temedica, we have found an expert with regards to
health data analytics and interpretation. Together, we can advance the potential
of health data to gain unprecedented insights to support scientific and medical
research, product development and, more generally, the scientific community
and physicians."

About NOVENTI

The NOVENTI Group, a Munich, Germany-based health services company, combines a large number
of separate individual brands and companies with a wide range of products and services. NOVENTI is
one of the leading suppliers of software, financial services and digital platforms within the European
healthcare market. Its product offering aims to provide 360-degree-services for all players in the
healthcare sector, such as pharmacies, healthcare service providers, physicians, nursing facilities, etc.
To ensure future viability and sustainable development, NOVENTI accompanies its customers
throughout digital transformation processes such as the implementation of e-prescribing, health
information exchange infrastructure and electronic health record (EHR) deployment. NOVENTI offers
hybrid solutions and enables healthcare providers to connect with their patients and customers. The
goal of NOVENTI - and all of its individual companies - is to be at the forefront of tomorrow’s
healthcare market by offering innovative products, services, and solutions. The company was founded
in 1900 to represent the interests of a group of Munich-based pharmacists (today known as FSA).
NOVENTI comprises over 2,000 employees, and generated an annual revenue of over 200 million
euros in 2020. Further information is available at https://www.noventi.de/en/.

About Permea

Permea is a new offering from Temedica available to different stakeholders in the healthcare space.
Permea combines multiple data sources, including longitudinal, patient-generated data with high
resolution related to time, geography, and patient cohorts. Its customizable solutions provide insights
into various challenges along the healthcare value chain, including research and development,
regulatory approvals, market launches and commercialization of therapies. Permea Insights and
Permea Monitor provide in-depth knowledge about therapies and their effects under real-world
conditions, allowing better informed decisions. Based on artificial intelligence and innovative
algorithms, Permea provides answers to industry relevant questions. All Permea operations comply
with the General Data Protection Regulation (GDPR) laws on data protection and security and also
meet the high standards internationally. For more information, please visit www.permea-health.com.

About Temedica GmbH

Temedica is a Munich, Germany-based digital health and health insights company with the mission to
bring the patient into the center of healthcare. The company develops state-of-the-art digital patient
companions for complex, chronic conditions. These apps support patients with personalized guidance
and help them navigate healthcare systems by considering their individual needs. Through direct and
long-term interaction with patients, Temedica generates unique and previously unknown real-world
evidence about disease progression and the individual effectiveness of therapies. Temedica has
expertise in the personalized support of patients as well as in compiling, structuring, and analyzing
respective health data. Its data analytics platform Permea is designed to enable unique insights along
the entire healthcare value chain and patient journey. Temedica is supported by a consortium of
renowned investors with longstanding track-records in the biopharmaceutical industry, including the
founding investors of BioNTech. Further information is available at https://temedica.com/en/.

For further information please contact:

International Media and IR Contact
Dr. Brigitte Keller, Katja Arnold
T +49 89 210228 0
UK: Shaun Brown
M: +44 7867 515 918
Email: temedica@mc-services.eu